Ceapro (CVE:CZO) Stock Price Down 11.8% – Here’s Why

Ceapro Inc. (CVE:CZO) fell 11.8% during trading on Wednesday . The company traded as low as C$0.23 and last traded at C$0.23. 5,850 shares traded hands during trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.

Ceapro Stock Performance

The stock has a market cap of C$17.62 million, a P/E ratio of -3.75 and a beta of 1.38. The company has a debt-to-equity ratio of 8.07, a current ratio of 8.54 and a quick ratio of 18.88. The company has a fifty day moving average of C$0.22 and a 200 day moving average of C$0.23.

Ceapro Company Profile

Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.